Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 78 peer-reviewed journal articles Updated
Gastroenterology

Chronic Atrophic Gastritis: A Patient Guide

At a Glance

Chronic atrophic gastritis is long-term inflammation that reduces stomach glands and can impair iron and vitamin B12 absorption. It is not cancer, but regular blood tests, nutrient replacement, and individualized endoscopic surveillance help manage deficiencies and monitor long-term risk.

What this diagnosis does and does not mean: Chronic atrophic gastritis is not the same as cancer. Not everyone with the condition has symptoms or nutrient deficiencies, and individual risk depends on the cause, extent, metaplasia, pathology, and family history.

Chronic atrophic gastritis (CAG) is a condition defined by the long-term inflammation and gradual loss of the stomach’s normal glands [1]. These glands are the “machinery” of your stomach, responsible for producing the acid that digests food and the proteins needed to absorb essential vitamins. When these glands are replaced by less specialized tissue—a process called atrophy—the stomach loses its ability to perform these vital functions, leading to changes that can affect your entire body [2][3].

The condition generally follows one of two paths. The first is autoimmune metaplastic atrophic gastritis (AMAG), where the immune system mistakenly attacks the parietal cells in the top part of the stomach, which reduces intrinsic-factor production [4]. The second is environmental metaplastic atrophic gastritis (EMAG), which is most often triggered by a long-term infection with H. pylori bacteria [5]. While the causes differ, both forms can lead to a stomach environment that is less efficient at processing life-sustaining nutrients [6].

When symptoms occur, this loss of “stomach machinery” can explain the unexplained fatigue and weakness that many patients experience for years before diagnosis, though fatigue, brain fog, and digestive symptoms are nonspecific and still need evaluation for other causes. Without enough stomach acid and specialized proteins, your body cannot properly absorb iron or Vitamin B12 [7]. Left untreated, these deficiencies can lead to anemia, memory issues, and nerve damage [8][9]. One of the most empowering parts of a diagnosis is the ability to bypass the damaged stomach using targeted supplements or injections, which can often help when a documented deficiency caused the symptoms, though recovery varies [10][11].

It is natural to feel concerned when you hear that CAG is a “premalignant” condition, meaning it can increase the risk of certain stomach growths over many years [12]. However, this risk is highly manageable and does not mean cancer is inevitable. By participating in regular surveillance—periodic endoscopies to monitor the stomach lining—doctors can identify and manage any changes to reduce your risk [13][14]. For the vast majority of people, chronic atrophic gastritis is not a crisis, but a manageable health state that, once understood, allows you to live a full and active life.

In this guide

6 chapters

01

Understanding Chronic Atrophic Gastritis: Validation & Orientation

Learn what chronic atrophic gastritis means, how biopsy results confirm it, why iron or B12 deficiency can occur, and how gastric cancer risk is monitored.

02

Symptoms, Warning Signs & When to Seek Urgent Care

Learn the symptoms of chronic atrophic gastritis, including iron and B12 deficiency, nerve changes, and when stomach or neurological signs need urgent care.

03

How It Works: Autoimmune vs. Environmental Gastritis

Learn how autoimmune and environmental chronic atrophic gastritis differ, including H. pylori, biopsy patterns, gastrin, thyroid links, and key tests to discuss.

04

Decoding Your Pathology Report and Staging

Learn how to read a chronic atrophic gastritis pathology report, including biopsy mapping, OLGA and OLGIM stages, metaplasia type, H. pylori, and dysplasia.

05

Standard of Care: Treating the Causes and Deficiencies

Learn how chronic atrophic gastritis treatment addresses H. pylori, B12 and iron deficiencies, Type 1 NETs, follow-up testing, and long-term monitoring.

06

Surveillance and Long-term Monitoring

Learn how chronic atrophic gastritis surveillance works, including endoscopy intervals, OLGA/OLGIM stages, risk factors, type 1 NET follow-up, and scan anxiety.

Common questions in this guide

Does chronic atrophic gastritis mean I have stomach cancer?
No. Chronic atrophic gastritis is not cancer, but it is considered a premalignant condition because long-term changes in the stomach lining can raise the risk of certain stomach growths. The level of risk varies with the cause, extent of atrophy or metaplasia, pathology findings, and family history, so follow-up is individualized.
What causes the autoimmune and H. pylori forms of atrophic gastritis?
The autoimmune form, called AMAG, occurs when the immune system attacks stomach cells that make acid and intrinsic factor. The environmental form, called EMAG, is most often linked to long-term H. pylori infection. Biopsy findings and clinical testing help clinicians assess which pattern is present.
Why are iron and vitamin B12 checked in chronic atrophic gastritis?
The loss of stomach glands can reduce stomach acid and intrinsic factor, making it harder to absorb iron and vitamin B12. Low levels can contribute to anemia, fatigue, brain fog, memory problems, or nerve symptoms such as numbness and tingling. Supplements or injections may help when a deficiency is documented, but treatment targets and follow-up should be individualized.
What symptoms can chronic atrophic gastritis cause?
Some people have no symptoms, while others develop fatigue, weakness, brain fog, or digestive symptoms. Iron or vitamin B12 deficiency can contribute to anemia, memory changes, or nerve symptoms. These complaints are nonspecific, so other possible causes still need evaluation.
How is chronic atrophic gastritis monitored over time?
Monitoring may include periodic blood tests for iron and vitamin B12 and endoscopies to examine the stomach lining. The schedule depends on the cause, the extent of atrophy or metaplasia, pathology findings, and family history. Ask your clinician whether your biopsy results, including any OLGA or OLGIM stage, call for regular surveillance.
Can a negative H. pylori test rule out infection?
Not always. A negative result may need to be interpreted in context, including the test used and the effects of low stomach acid or other factors that can reduce detection. Your clinician can decide whether repeat or different testing is appropriate.

Get notified when new evidence is published on chronic atrophic gastritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.

    Shah SC, Piazuelo MB, Kuipers EJ, Li D

    Gastroenterology 2021; (161(4)):1325-1332.e7 doi:10.1053/j.gastro.2021.06.078.

    PMID: 34454714
  2. 2

    The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective.

    Massironi S, Zilli A, Elvevi A, Invernizzi P

    Autoimmunity reviews 2019; (18(3)):215-222 doi:10.1016/j.autrev.2018.08.011.

    PMID: 30639639
  3. 3

    Pathophysiology and laboratory diagnosis of pernicious anemia.

    Toh BH

    Immunologic research 2017; (65(1)):326-330 doi:10.1007/s12026-016-8841-7.

    PMID: 27538411
  4. 4

    Autoimmune gastritis: Pathologist's viewpoint.

    Coati I, Fassan M, Farinati F, et al.

    World journal of gastroenterology 2015; (21(42)):12179-89 doi:10.3748/wjg.v21.i42.12179.

    PMID: 26576102
  5. 5

    Atrophic gastritis of distinct etiologies: malignant potential in Helicobacter pylori-associated and autoimmune forms.

    Rokkas T, Rugge M

    Annals of gastroenterology 2026; (39(3)):283-293 doi:10.20524/aog.2026.1065.

    PMID: 42164610
  6. 6

    Autoimmune atrophic gastritis: current perspectives.

    Minalyan A, Benhammou JN, Artashesyan A, et al.

    Clinical and experimental gastroenterology 2017; (10()):19-27 doi:10.2147/CEG.S109123.

    PMID: 28223833
  7. 7

    Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review.

    Cavalcoli F, Zilli A, Conte D, Massironi S

    World journal of gastroenterology 2017; (23(4)):563-572 doi:10.3748/wjg.v23.i4.563.

    PMID: 28216963
  8. 8

    Autoimmune Atrophic Gastritis: A Clinical Review.

    Castellana C, Eusebi LH, Dajti E, et al.

    Cancers 2024; (16(7)) doi:10.3390/cancers16071310.

    PMID: 38610988
  9. 9

    Autoimmune Gastritis.

    Hall SN, Appelman HD

    Archives of pathology & laboratory medicine 2019; (143(11)):1327-1331 doi:10.5858/arpa.2019-0345-RA.

    PMID: 31661309
  10. 10

    Chronic Atrophic Gastritis Presenting as Hemolytic Anemia due to Severe Vitamin B12 Deficiency.

    Woodford AM, Chaudhry R, Conte GA, et al.

    Case reports in hematology 2021; (2021()):9571072 doi:10.1155/2021/9571072.

    PMID: 34373795
  11. 11

    Vitamin B12 Deficiency: Recognition and Management.

    Langan RC, Goodbred AJ

    American family physician 2017; (96(6)):384-389.

    PMID: 28925645
  12. 12

    OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.

    Rugge M, Genta RM, Fassan M, et al.

    The American journal of gastroenterology 2018; (113(11)):1621-1628 doi:10.1038/s41395-018-0353-8.

    PMID: 30333540
  13. 13

    Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025.

    Dinis-Ribeiro M, Libânio D, Uchima H, et al.

    Endoscopy 2025; (57(5)):504-554 doi:10.1055/a-2529-5025.

    PMID: 40112834
  14. 14

    AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review.

    Shah SC, Wang AY, Wallace MB, Hwang JH

    Gastroenterology 2025; (168(2)):405-416.e1 doi:10.1053/j.gastro.2024.11.001.

    PMID: 39718517

This page is for informational purposes only and does not constitute medical advice. Your gastroenterologist or other clinician should interpret your biopsies, blood tests, and surveillance needs.